20.01.2016 Views

Global Non-Invasive Prenatal Testing (NIPT) Market by P&S Market Research

Based on test type, the MaterniT21 PLUS segment led the global NIPT market in 2014 with the largest market size. It was the first test introduced in the market for the diagnosis of Trisomy 21, in 2011. However, the NIFTY test segment is expected to grow with the fastest rate, among the various test type segments during the forecast period.

Based on test type, the MaterniT21 PLUS segment led the global NIPT market in 2014 with the largest market size. It was the first test introduced in the market for the diagnosis of Trisomy 21, in 2011. However, the NIFTY test segment is expected to grow with the fastest rate, among the various test type segments during the forecast period.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Global</strong> <strong>Non</strong>-<strong>Invasive</strong> <strong>Prenatal</strong> <strong>Testing</strong> (<strong>NIPT</strong>) <strong>Market</strong> is Expected to Grow at<br />

17.6% CAGR During 2015 – 2020<br />

8.1.7.2 Product and service offerings<br />

8.1.8 LifeCodexx AG<br />

8.1.8.1 Business overview<br />

8.1.8.2 Product and service offerings<br />

8.1.9 Natera, Inc.<br />

8.1.9.1 Business overview<br />

8.1.9.2 Product and service offerings<br />

8.2 Strategic Developments in the <strong>NIPT</strong> <strong>Market</strong><br />

8.2.1 Mergers & acquisitions<br />

8.2.2 Collaborations and partnerships<br />

8.2.3 Product approval/ launch<br />

8.2.4 Other developments<br />

Chapter 9. Appendix<br />

9.1 List of Abbreviations<br />

Request for Report Sample: https://www.psmarketresearch.com/market-analysis/non-invasive-prenatal-testingmarket/report-sample<br />

LIST OF TABLES<br />

TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION<br />

TABLE 2 GLOBAL <strong>NIPT</strong> MARKET SNAPSHOT<br />

TABLE 3 MAJOR COLLABORATIONS AND PARTNERSHIPS IN THE <strong>NIPT</strong> MARKET<br />

TABLE 4 RISK OF DOWN SYNDROME AND CHROMOSOMAL ABNORMALITIES AT LIVE BIRTH<br />

© P&S <strong>Market</strong> <strong>Research</strong>. All rights reserved 6

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!